12/10/2020 - 14:03

Major clinical study validates Proteomics kidney test

12/10/2020 - 14:03

Bookmark

Save articles for future reference.

ASX-listed Proteomics International has published the findings of a major international, multi-centre clinical study involving more than 3,500 patients which provides the first-ever external support for the efficacy of its PromarkerD diagnostic test. Extraordinarily, patients identified by PromarkerD were 13.5 times more likely to develop Chronic Kidney Disease during a 4-year period.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options